Home » Topics » BioWorld Science

BioWorld Science
RSS

Prothena reorganizing resources to advance neuroscience pipeline

May 29, 2018

Polysialic acid levels tied to prostate cancer aggressiveness

May 28, 2018

Mepolizumab approved for EGPA in Japan

May 28, 2018

Symphogen opens enrollment in phase I study of Sym-023 in advanced solid tumors or lymphomas

May 28, 2018

MedImmune initiates phase I study of MEDI-2228 in relapsed or refractory multiple myeloma

May 28, 2018

New phase I study evaluates MRX-2843 in patients with advanced or metastatic solid tumors

May 28, 2018

Roche presents compounds for HBV infection

May 28, 2018

Braeburn resubmits CAM-2038 NDA for opioid use disorder to FDA

May 28, 2018

Janssen Pharmaceutica discloses BACE1 and/or BACE2 inhibitors

May 28, 2018

Pfizer's Xeljanz approved for new indication in Japan

May 28, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...